SCHEMBL7948815

SCHEMBL7948815

CC1CCNC(C(=O)c2ccc3c(c2)CCCN3C(=O)CCc2ccc(C#N)cc2)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.42
HDAC1 Q13547 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
IDO1 P14902 1/20 0.37
KCNH2 Q12809 1/20 0.37
ALDH1A1 P00352 3/20 0.36
HPGD P15428 2/20 0.36
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
TSHR P16473 1/20 0.36
KMT2A Q03164 1/20 0.36
HSD17B10 Q99714 1/20 0.36
PARP1 P09874 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
NPC1 O15118 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
RAB9A P51151 1/20 0.35
KDM2B Q8NHM5 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7410530 0.82 TP53 (0.45) TP53HDAC1HDAC8HDAC6ALDH1A1
SCHEMBL6985351 0.81 ALDH1A1 (0.54) TP53HDAC1HDAC8HDAC6ALDH1A1
SCHEMBL6985246 0.79 TP53 (0.51) TP53HDAC1HDAC8HDAC6IDO1
SCHEMBL6986538 0.77 TP53 (0.49) TP53HDAC1HDAC8HDAC6IDO1
SCHEMBL7948828 0.77 ITK (0.45) TP53HDAC1HDAC8HDAC6ALDH1A1
SCHEMBL6981826 0.77 PDK1 (0.52) TP53HDAC1HDAC8HDAC6ALDH1A1
SCHEMBL6977395 0.77 TP53 (0.46) TP53HDAC1HDAC8HDAC6ALDH1A1
SCHEMBL6979174 0.75 TP53 (0.50) TP53HDAC1HDAC8HDAC6IDO1
SCHEMBL6979722 0.75 TP53 (0.48) TP53HDAC1HDAC8HDAC6ALDH1A1
SCHEMBL6984356 0.75 SMN1; SMN2 (0.53) TP53HDAC1HDAC8HDAC6SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed